If you’re an advocate, policy maker or expert working on drug-resistant infections, you often need to write convincingly to make your audience understand and care about the issue. Here are some practical examples to help you do that.
People with fewer educational qualifications are just as interested in health research, even if they engage less with it, Wellcome Monitor finds. Could engagement practices themselves be a barrier to inclusive engagement?
The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control future outbreaks?
The impact of drug-resistant infections is much higher than previously thought, as shown in a new report from the Centers for Disease Control.
Research culture is often underpinned by the decisions that funders make and how they make them. But what is the best way to decide who to fund?